Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies

FHS
March 18, 2024
11:08 am

Immunome signs deal to use Arrayjet platform in its in-house screening operations.

Roche touts full data for drug in first-line PIK3CA-mutated breast cancer

Roche’s breast cancer combination of inavolisib plus palbociclib and fulvestrant showed off new data Friday, with the company touting a 57% reduction in the risk

December 9, 2023

ERC Advanced Grant aids study on ubiquitin in DNA repair and genome stability

Professor Helle Ulrich, Executive Director of the Institute of Molecular Biology (IMB) and professor at Johannes Gutenberg University Mainz (JGU), has been awarded an Advanced

June 28, 2024

TB cases in England increase by 7% in the first half of 2023

Data from the UK Health Security Agency (UKHSA) indicates that cases of TB in England increased by 7% in the first half of 2023 compared

September 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.